What caused the ALSGD.PA stock drop today?

ALSGD.PA stock fell after hours due to heavier selling and weak short-term momentum. Volume rose to **2,501,828**, and the stock trading below the 50-day average likely triggered stop orders.

What is the Meyka AI forecast for ALSGD.PA stock?

Meyka AI's forecast model projects **€0.07** monthly and **€0.06** quarterly. The monthly projection implies **-29.29%** versus the current **€0.099**. Forecasts are model-based projections and not guarantees.

Is ALSGD.PA stock a buy after the drop?

ALSGD.PA stock presents high risk. Meyka AI issues a **B / HOLD** grade. Investors should wait for revenue uplift, cash improvements, or clear clinical progress before buying.

What are the key financial ratios for ALSGD.PA stock?

Key ratios include EPS **-0.04**, PE **-2.69**, P/S **1.55**, P/B **1.36**, and Debt/Equity **0.54**. Current ratio is **1.07**, indicating limited short-term liquidity.

EU Stocks

ALSGD.PA SpineGuard SA EURONEXT down 8.33% on 09 Jan 2026: assess recovery

ByDanny Kontos January 9, 2026

The ALSGD.PA stock slid 8.33% after hours to €0.099 on 09 Jan 2026, paced by heavier-than-average trade and weak short-term momentum. Volume reached 2,501,828 shares versus average 1,621,077, signalling elevated selling interest in EURONEXT trading in Europe. The move follows a recent pattern of sharp intraday swings and positions SpineGuard SA against a €0.0755 year low and €0.299 year high.